Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Rynne (London, United Kingdom), M. Plate (London, United Kingdom), R. Chambers (London, United Kingdom), P. Howarth (Southampton, United Kingdom), R. Martinez-Nunez (London, United Kingdom). LSC - 2019 - Post-transcriptional dysregulation as a novel mechanism underlying non-responsive severe asthma. 2369

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD Source: International Congress 2016 – Airway response to infection Year: 2016 LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 CD39/CD73/A2AR pathway may involve in the occurrence allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Identification of molecular pathways in distinct asthma phenotypes identified in ADEPT Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 FKBP5 a candidate for corticosteroid insensitivity in COPD Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Involvement of epigenetic factor in regulation of steroid resistant bronchial asthma patients Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 microRNA–mRNA regulatory networks underlying chronic mucus hypersecretion in COPD Source: Eur Respir J, 52 (3) 1701556; 10.1183/13993003.01556-2017 Year: 2018 Cellular mechanisms underlying steroid refractory asthma Source: ERS Lung Science Conference 2019 Year: 2019 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Physiological mechanisms of compensatory responses of the respiratory system to central hypervolemia: A modeling study Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS) Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019